Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Am J Kidney Dis. 2011 Feb;57(2):245–254. doi: 10.1053/j.ajkd.2010.09.027

Table 1.

Demographic, Clinical, and Nutrient Characteristics of NHS Participants in the Year 2000 Stratified by Western Pattern Diet Score

Cumulative Averaged Western Pattern Diet Score
All NHS (N= 3121) Q1 n=780 Q2 n=780 Q3 n=781 Q4 n=780 p-for-trend
Age (years) 67 (62, 73) 69 (63, 74) 67 (62, 73) 66 (61, 72) 65 (59, 71) <.001
Caucasian (%) 97.4 96.1 97.1 98.3 98.2 0.02
Hypertension (%) 54.1 53.1 44.9 43.4 42.2 <.001
SBP (mm/hg) in 1990 130 (120, 140) 120 (110, 130) 130 (120, 140) 130 (120, 140) 130 (120, 140) <.001
DBP (mm/hg) in 1990 105 (70, 80) 80 (70, 80) 80 (70, 80) 80 (70, 88) 80 (70, 88) <.001
Diabetes (%) 23.1 17.1 22.8 23.8 28.6 <.001
High cholesterol (%) 65.0 66.3 66.3 65.4 61.8 0.2
CVD (%) 6.0 6.4 6.0 5.4 6.0 0.9
Current smoker (%) 5.8 3.0 4.6 5.8 9.7 <.001
Ever smoker (%) 52.8 52.8 54.6 51.5 52.2 0.6
Alcohol intake (g/day) 1.7 (0.18, 7.0) 1.9 (0.2, 7.1) 2.1 (0.4, 8.0) 1.9 (0.2, 7.4) 1.2 (0, 5.7) 0.2
Calorie intake (kcal/day) 1726 (1468, 2020) 1413 (1230, 1626) 1607 (1408,1805) 1800 (1605, 1996) 2153 (1923, 2392) <.001
Activity level (METs/week) 11.4 (3.6, 25.2) 14.0 (4.3, 27.9) 12.7 (4.1, 26) 11.5 (4.0, 24.6) 8.1 (2.4, 20.8) <.001
BMI (kg/m2) 26.4 (23, 30.2) 25.0 (22.3, 28.7) 26.4 (23.3, 30) 26.6 (23.2, 30.1) 27.5 (23.5, 32.0) <.001
Aspirin use lifetime (g/day) 748 (98, 3169) 414 (33, 2438) 748 (82, 3006) 813 (98, 3656) 975 (98, 3656) 0.01
NSAID use lifetime (g/day) 60 (10, 1000) 20 (10, 500) 50 (10, 900) 100 (20, 1200) 100 (20, 1500) 0.06
Acetominophen use through 1999 (g/day) 98 (33, 1138) 81 (33, 650) 98 (33, 98) 98 (33, 1138) 260 (33, 2438) 0.001
ACEi or ARB medication use (%) 21.3 18.7 20.3 23.9 22.2 0.06
Cholesterol lowering medication (ever used by year 2000) 28.8 32.2 27.3 28.6 27.2 0.1
Plasma Cr in 2000 (mg/dl) 0.8 (0.7, 0.9) 0.8 (0.7, 0.9) 0.8 (0.7, 0.9) 0.8 (0.7, 0.9) 0.8 (0.7, 0.9) 0.9
eGFR in 2000 (ml/min/1.73 m2) 76 (65, 88) 76 (65, 88) 76 (65, 87) 76 (65, 88) 76 (66, 89) 0.9
Urinary ACR (mcg/mg) 3.4 (2.0, 6.2) 3.3 (2.1, 6.2) 3.3 (1.9, 6.0) 3.4 (1.9, 6.2) 3.4 (2.0, 6.1) 0.9
Total protein (g/day) 74 (68, 80) 76 (69, 83) 75 (69, 81) 73 (68, 79) 72 (66, 77) <.001
Animal protein (g/day) 53 (46, 59) 54 (47, 61) 53 (47, 59) 52 (46, 58) 51 (46, 58) <.001
Vegetable protein (g/day) 21 (19, 23) 22 (20, 25) 21 (19, 23) 21 (19, 23) 20 (18, 22) <.001
Total fat (g/day) 56 (50, 61) 49 (44, 55) 54 (50, 59) 57 (53, 62) 60 (56, 65) <.001
Animal fat (g/day) 30 (25, 34) 26 (22, 30) 29 (25, 33) 31 (27, 35) 33(29, 37) <.001
Sodium (mg/d) 2001 (1801, 2227) 1907 (1718, 2116) 1981 (1781, 2181) 2033 (1827, 2262) 2085 (1888, 2325) <.001
Beta-carotene (mg/day) 4406 (3281, 5930) 5763 (4198,7522) 4651 (3499,5851) 4031 (3216,5344) 3620 (2732,4727) <.001
Median Western Diet pattern score −0.1 (−0.6, 0.4) −0.9 (−1.1, −0.7) −0.3 (−0.5, −0.2) 0.1 (0.0, 0.3) 0.9 (0.7, 1.3) NA

Results expressed as median (25th, 75th percentile), percentage, or median (percentage). Conversion factors for units: Cr in mg/dL to μmol/L, x88.4; eGFR in mL/min/1.73 m2 to mL/s/1.73 m2, x0.01667.

*

p<0.05 or

**

p<0.01 when compared to Q1 as referent group

ACR= albumin-creatinine ratio; eGFR=estimated glomerular filtration rate; Cr, creatinine; NA, Not applicable; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ACR, albumin-creatinine ratio; CVD, cardiovascular disease; BMI, body mass index; NSAID, nonsteroidal antiiinflamatory drugs; Q, quartile; MET, metabolic equivalent; NHS, Nurses’ Health Study